Clinical Trials Browser

Phase 2 × romiplostim × Clear all

NCT04671901 2025-05-28

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase 2 Terminated

2 enrolled 4 charts

Other solid neoplasm

Solid Tumor

NCT04478123 2024-02-14

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Phase 2 Completed

62 enrolled 7 charts

Classical hematologyLymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Thrombocytopenia

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

Phase 2 Suspended

Melanoma

NCT01516619 2022-08-12

ProRom

Phase 2 Completed

Lymphoma, Non-Hodgkin

NCT03622931 2021-02-08

TRACEII

Phase 2 Terminated

Neoplasms, Ovarian Neoplasms

NCT01676961 2018-10-15

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Phase 2 Terminated

5 enrolled 4 charts

Classical hematologyPlasma cell

Multiple Myeloma, Thrombocytopenia

NCT02227576 2018-04-25

PLATUM

Phase 2 Terminated

CNSClassical hematology

Glioblastoma, Thrombocytopenia

NCT00413283 2013-10-24

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

63 enrolled 15 charts

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Thrombocytopenia